Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 )

NCT03403140 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Etanercept

Sponsor

Gema Biotech S.A.

Collaborators

[object Object]